TrialJournal of the National Cancer Institute2015

Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.

Ranjit Manchanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.